SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters - Practical use of viral load for disease control
- PMID: 35395500
- PMCID: PMC8920080
- DOI: 10.1016/j.jcv.2022.105131
SARS-CoV-2 transmitters have more than three times higher viral loads than non-transmitters - Practical use of viral load for disease control
Abstract
Background: Quantitative results of SARS-CoV-2 testing reported as viral load copies/mL can provide valuable information, but are rarely used in practice. We analyze whether viral load in the upper respiratory tract is correlated with transmission and disease course and how this information can be used in practice.
Study design: Municipal Health Service (MHS) and clinical patients ≥18 years tested positive for SARS-CoV-2 with RT-PCR between June 1 and September 25, 2020 were included. Transmission was defined as an index having at least one contact tested positive. Test delay was defined as the time between symptom onset and SARS-CoV-2 testing.
Results: 683 patients were included (656 MHS and 27 clinical patients). The viral load was considerably lower among clinical patients compared to MHS patients: median log10 copies/mL 2.51 (IQR -1.52 - 6.46) vs 4.92 (IQR -0.54 - 8.26), p < 0.0001. However, the test delay was higher for clinical patients (median 7 [IQR 2 - 19] vs 3 [IQR 0 - 26] days, p < 0.0001). SARS-CoV-2 transmitters showed much higher viral loads than non-transmitters (log10 copies/mL 5.23 [IQR -0.52 - 8.26] vs 4.65 [IQR -0.72 - 8.00], p < 0.0001), but not for those with a test delay > 7 days. Higher viral loads were significantly correlated with older age and with more (severe) COVID-19 related symptoms.
Conclusion: Indexes that transmitted SARS-CoV-2 had more than three times higher viral loads than non-transmitters. Viral load information can be useful during source and contact tracing to prioritize indexes with highest risk of transmission, taking into account the test delay.
Keywords: COVID-19; SARS-CoV-2; Test delay; Transmission; Viral load.
Copyright © 2022. Published by Elsevier B.V.
Conflict of interest statement
All authors declare no competing interests.
Figures





Similar articles
-
Transmission of COVID-19 in 282 clusters in Catalonia, Spain: a cohort study.Lancet Infect Dis. 2021 May;21(5):629-636. doi: 10.1016/S1473-3099(20)30985-3. Epub 2021 Feb 2. Lancet Infect Dis. 2021. PMID: 33545090 Free PMC article.
-
Assessment of Clinical and Virological Characteristics of SARS-CoV-2 Infection Among Children Aged 0 to 4 Years and Their Household Members.JAMA Netw Open. 2022 Aug 1;5(8):e2227348. doi: 10.1001/jamanetworkopen.2022.27348. JAMA Netw Open. 2022. PMID: 36044218 Free PMC article.
-
Upper respiratory tract SARS-CoV-2 RNA loads in symptomatic and asymptomatic children and adults.Clin Microbiol Infect. 2021 Dec;27(12):1858.e1-1858.e7. doi: 10.1016/j.cmi.2021.08.001. Epub 2021 Aug 9. Clin Microbiol Infect. 2021. PMID: 34384874 Free PMC article.
-
SARS-CoV-2 RNAemia with a higher nasopharyngeal viral load is strongly associated with disease severity and mortality in patients with COVID-19.J Med Virol. 2022 Jan;94(1):147-153. doi: 10.1002/jmv.27282. Epub 2021 Aug 25. J Med Virol. 2022. PMID: 34411312 Free PMC article.
-
[SARS-CoV-2 and Microbiological Diagnostic Dynamics in COVID-19 Pandemic].Mikrobiyol Bul. 2020 Jul;54(3):497-509. doi: 10.5578/mb.69839. Mikrobiyol Bul. 2020. PMID: 32755524 Review. Turkish.
Cited by
-
Nasopharyngeal Wash with Normal Saline Decreases SARS-CoV-2 Viral Load: A Randomized Pilot Controlled Trial.Can Respir J. 2022 Sep 27;2022:8794127. doi: 10.1155/2022/8794127. eCollection 2022. Can Respir J. 2022. PMID: 36247079 Free PMC article. Clinical Trial.
-
Washing Illness Away: A Systematic Review of the Impact of Nasal Irrigation and Spray on COVID-19.Laryngoscope. 2025 Feb;135(2):517-528. doi: 10.1002/lary.31761. Epub 2024 Sep 13. Laryngoscope. 2025. PMID: 39268910 Free PMC article.
-
A Prospective Study of Key Correlates for Household Transmission of Severe Acute Respiratory Syndrome Coronavirus 2.Open Forum Infect Dis. 2023 May 23;10(7):ofad271. doi: 10.1093/ofid/ofad271. eCollection 2023 Jul. Open Forum Infect Dis. 2023. PMID: 37416758 Free PMC article.
-
SARS-CoV-2 Testing of Emergency Department Patients Using cobas® Liat® and eazyplex® Rapid Molecular Assays.Diagnostics (Basel). 2023 Jul 1;13(13):2245. doi: 10.3390/diagnostics13132245. Diagnostics (Basel). 2023. PMID: 37443639 Free PMC article.
-
Differential expression of antiviral and immune-related genes in individuals with COVID-19 asymptomatic or with mild symptoms.Front Cell Infect Microbiol. 2023 Jun 14;13:1173213. doi: 10.3389/fcimb.2023.1173213. eCollection 2023. Front Cell Infect Microbiol. 2023. PMID: 37389217 Free PMC article.
References
-
- Meyerowitz E.A., Richterman A., Gandhi R.T., Sax P.E. Transmission of SARS-CoV-2: A Review of Viral, Host, and Environmental Factors. Ann. Intern. Med. 2021;174:69–79. doi: 10.7326/M20-5008. https://doi.org/ - DOI - PMC - PubMed
-
- van Kampen J.J.A., van de Vijver D.A.M.C., Fraaij P.L.A., et al. Duration and key determinants of infectious virus shedding in hospitalized patients with coronavirus disease-2019 (COVID-19) Nat. Commun. 2021;12:267. doi: 10.1038/s41467-020-20568-4. https://doi.org/ - DOI - PMC - PubMed
-
- Walsh K.A., Jordan K., Clyne B., et al. SARS-CoV-2 detection, viral load and infectivity over the course of an infection. J. Infect. 2020;81:357–371. doi: 10.1016/j.jinf.2020.06.06701. https://doi.org/ - DOI - PMC - PubMed
MeSH terms
LinkOut - more resources
Full Text Sources
Medical
Miscellaneous